NCGC00244536
CAS No. 2003260-55-5
NCGC00244536 ( KDM4B Inhibitor B3 )
产品货号. M22057 CAS No. 2003260-55-5
NCGC00244536 是一种有效的 KDM4B 抑制剂 (IC50: 10 nM)。NCGC00244536 有效抑制 AR 阳性细胞系。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥2649 | 有现货 |
|
| 10MG | ¥4026 | 有现货 |
|
| 25MG | ¥6423 | 有现货 |
|
| 50MG | ¥9153 | 有现货 |
|
| 100MG | ¥12312 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称NCGC00244536
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述NCGC00244536 是一种有效的 KDM4B 抑制剂 (IC50: 10 nM)。NCGC00244536 有效抑制 AR 阳性细胞系。
-
产品描述NCGC00244536 is a potent KDM4B inhibitor (IC50: 10 nM).NCGC00244536 effectively inhibits AR-positive cell lines, including LNCaP and VCaP, with IC50s in the sub-micromolar range, and abolishes androgen-stimulated LNCaP cell growth. NCGC00244536 displays high selectivity for the fast-growing AR-negative PC3 cells (IC50: 40 nM) and over 100-fold selectivity against the immortalized prostate epithelial cell lines PrEC1 and PrEC4. NCGC00244536 is also potent in inhibiting the growth of other cancer cell lines, including the breast cancer cell lines MDA-MB2 and MCF-7, with micromolar IC50s.Treatment with NCGC00244536 results in significant inhibition of tumor growth and animals do not exhibit any major toxicity and appear to be normal. NCGC00244536-treated tumors have a significant amount of cell apoptosis, necrosis, and fibrosis.
-
体外实验——
-
体内实验——
-
同义词KDM4B Inhibitor B3
-
通路Chromatin/Epigenetic
-
靶点Histone Demethylase
-
受体KDM4B
-
研究领域——
-
适应症——
化学信息
-
CAS Number2003260-55-5
-
分子量382.45
-
分子式C25H22N2O2
-
纯度>98% (HPLC)
-
溶解度DMSO:100 mg/mL (261.47 mM)
-
SMILESOC1=C2N=CC=CC2=CC(=C1)C1=CC(=CC=C1)C(=O)NCCCC1=CC=CC=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Duan L, et al. KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes. Chem Biol. 2015 Sep 17;22(9):1185-96.
产品手册
关联产品
-
LSD1-IN-27
LSD1-IN-27 (Compound 5ac) 是一种 LSD1 抑制剂 (IC50: 13 nM)。LSD1-IN-27 抑制胃癌细胞的干细胞性和迁移。LSD1-IN-27 还可降低 BGC-823 和 MFC 细胞中 PD-L1 的表达。LSD1-IN-27 可增强对胃癌的 T 细胞免疫反应。
-
KDM2B-IN-2
KDM2B-IN-1 是一种有效的组蛋白去甲基化酶 (KDM2B) 抑制剂,在 KDM2B TR-FRET 检测中 IC50 为0.021 μM。KDM2B-IN-1 可用于增生性疾病研究。
-
KDM4C-IN-1
KDM4C-IN-1 (Compound 4d) 是一种有效的 KDM4C 抑制剂,IC50 为 8 nM。KDM4C-IN-1 抑制 HepG2 和 A549 细胞的生长,IC50 分别为 0.8 μM 和 1.1 μM。
021-51111890
购物车()
sales@molnova.cn

